Trial intelligence / Profile preview

Human placenta extract with microneedling for facial skin wrinkles

IRCT20210612051545N3Phase 2Completed

Sponsor
Tehran University of Medical Sciences
Start
Sep 2022
Modality
Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 2, randomised trial comparing Microneedling + human placenta extract hydrogel with Microneedling + placebo saline (2 arms). Primary endpoint: Safety and tolerability of human placenta extract treatment. Started Sep 2022; status: completed.

02

Drugs

LAENNEC

Beyond the preview

Go deeper on IRCT20210612051545N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210612051545N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call